Bioprospecting medicinal plants for the isolation and screening of lovastatin producing endophytic fungi by Ravuri, Meena  & Shivakumar, Srividya 
Indian Journal of Natural Products and Resources 








Bioprospecting medicinal plants for the isolation and screening of lovastatin 
producing endophytic fungi 
Meena Ravuri and Srividya Shivakumar* 
Department of Microbiology, School of Sciences,  
18/3, 9th Main, Jayanagar 3rd Block, Jain University, Bangalore-560011, India 
Received 09 October 2019; Revised 10 February 2020 
Endophytic fungi reside within the plant tissues asymptomatically and produce various secondary metabolites of 
pharmaceutical interest. The current study aims to bio-prospect medicinal plants for the isolation and screening of lovastatin 
producing endophytic fungi. Endophytic population in the leaf, stem, root and flower (as applicable) of ten medicinal plants 
has been studied and their potential to produce the anti-hypercholesterolemia drug, lovastatin has been evaluated. A total of 
98 fungal isolates were obtained from the plant tissues and lovastatin yield from them was quantified to be within the range 
of 5 mg/L to 71.5 mg/L in the first round of submerged fermentation. The subsequent levels of screening witnessed a great 
change in the yield which could be attributed to gene attenuation, a usual phenomenon in endophytes. A novel lovastatin 
producer, designated as HL1, belonging to candida sp. residing within the leaves of Hibiscus rosa-sinensis was found to 
consistently yield higher amounts of lovastatin i.e., 40 mg/L through all rounds of screening, alongside two strains of 
Aspergillus sp., designated as HL4 and HL5, from the same tissue with a yield of 21.5 and 18 mg/L respectively. 
Preliminary confirmation of lovastatin presence in the fungal extract was done by Thin Layer Chromatography (TLC) and 
yeast growth inhibition bioassay. 
Keywords: Anti-hypercholesterolemia, Bioprospecting, Endophytic fungi, Lovastatin, Medicinal plants 
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Introduction 
The use of natural products in medicine dates back 
to ancient times. Natural products are secondary 
metabolites produced by various organisms as a 
defence mechanism in response to stress1. The natural 
products themselves or their principal molecules are 
potential candidates for drug development2. Globally, 
about 50% of the novel drug molecules approved for 
marketing between 1981 and 2002 were of natural 
origin3. However, exploitation of the natural products 
for the drug discovery has declined over the last few 
decades owing to the advent of combinatorial 
chemistry, metagenomics and high-throughput 
screening. Plants apart, microorganisms are an 
excellent source of metabolites with bioactive 
properties. Among the microorganisms, fungi, the 
most important group of eukaryotes are very well 
known for their ability to produce metabolites of 
clinical significance4. In the 1990s, around 1500 
fungal metabolites have been reported to possess 
anticancer and antibiotic properties5. 
Various soil fungi have been shown to produce 
lovastatin, the first statin approved by the FDA as an 
anti-hypercholesterolemia drug which eventually 
found its application in the treatment and management 
of various other chronic diseases including one of the 
global health challenges, cancer6. Other ecological 
habitats such as plant tissues have been less exploited 
for the isolation of potent lovastatin producers7, 8. 
 
This study aims to bio-prospect medicinal plants 
for the isolation and screening of lovastatin producing 
endophytic fungi. The mysterious existence of 
endophytic fungi for varying periods in the plant 
tissues and the consequent production of secondary 
metabolites by them in response to the stress induced 
by the host are of immense interest to the bio-
prospectors. They seem to be metabolically 
aggressive and versatile as compared to their 
counterparts in other niches since they ought to 
maintain a constant interaction with their host 
encountering the host defences and withstand the 
selection process through novel metabolic pathways9. 
The present study aims to exploit this potential of 









medicinal plants and screening for the production of 
lovastatin, one drug with many applications. 
Endophytic colonization is believed to benefit their 
host plant in three ways – enhancing the growth of 
host plant, conferring the plant with resistance to 
biotic and abiotic stresses and producing bioactive 
compounds that can be used as drugs10. The 
secondary metabolites produced by the endophytic 
fungi could be originally from plants as in the case of 
paclitaxel11, camptothecin, and its structural analogs12-14 
or those that were only produced by the host plants 
such as Artemisinin15. The ability of the endophytes 
to synthesize the same natural products as the host 
plant could be apparently due to horizontal gene 
transfer or genetic recombination between the host 
and the endophytes it harbors13. Nevertheless, the 
exact nature of the interaction between the endophytic 
microbe and the plant, plant products and processes 
involved are yet to be elucidated10. 
The rationale behind selecting medicinal plants as 
the source for bio-prospecting is that endophytic fungi 
associated with the medicinal plants were found to be 
promising sources of metabolites16-20. Besides, plants 
growing in unique environments and those with 
exceptional biology are also worth exploiting21. 
Different tissues of the selected host plants have been 
screened for endophytes rather than similar tissue 
from different plants since the endophytes were found 
to be tissue-specific rather than taxon-specific22,23. 
To the best of our knowledge, for the first time, 
novel lovastatin producing yeast belonging to 
Candida sp. residing within the leaves of Hibiscus 
rosa-sinensis was identified in this study. It is 
noteworthy that this strain exhibited consistency in its 
lovastatin production across two levels of screening 
with a yield of 40 mg/L under submerged conditions 
despite gene attenuation that occurs in endophytes as 
a result of continuous sub-culturing.  
 
Materials and Methods 
 
Sample collection 
Based on their therapeutic properties, ten 
medicinal plants namely Ocimum tenuiflorum, 
commonly known as holy basil (Family: Lamiaceae), 
Emblica officinalis, commonly known as gooseberry 
(Family: Phyllanthaceae), Moringa oleifera, 
commonly known as drumstick (Family: 
Moringaceae), Bacopa monnieri, commonly known as 
water hyssop (Family: Plantaginaceae), Murraya 
koenigii commonly known as curry leaf (Family: 
Rutaceae), Azadirachta indica, commonly known as 
neem (Family: Meliaceae), Hibiscus rosa-sinensis, 
commonly known as China rosa (Family: Malvaceae), 
Catharanthus roseus, commonly known as periwinkle 
(Family: Apocynaceae), Withania somnifera, 
commonly known as Indian ginseng (Family: 
Solanaceae) and Morinda citrifolia, commonly known 
as Indian mulberry (Family: Rubiaceae) have been 
shortlisted for the study and collected from the 
Department of Horticulture, Division of Aromatic and 
Medicinal Plants, University of Agricultural Sciences 
(UAS), GKVK, Bangalore. Leaves, stem, roots and 
flowers of the respective plant parts, as applicable, 
were studied for their endophytic population and 
lovastatin producing capacity. 
 
Samples identification 
Authentication of the plant was done by the 
Department of Botany, University of Agricultural 
Sciences (UAS), Bangalore. 
 
Isolation of endophytic fungi 
Leaves, stems, roots and flowers (as applicable) of 
the respective plants were surface sterilized using 
0.1% tween-80 (60 minutes), 70% v/v ethanol  
(15 seconds) and sodium hypochlorite (15 minutes), 
finally washed with distilled water and blot dried. The 
sterilized plant parts were cut into 0.5 cm x 0.5 cm 
and placed on streptomycin (150 mg/L) supplemented 
Potato Dextrose Agar (PDA) to prevent bacterial 
contamination and incubated at 25 °C for 2 weeks24. 
After the incubation period, hyphal tips associated 
with the plant tissue were transferred onto fresh PDA 
plates in pure culture followed by sub-culturing once 
in every four weeks. 
 
Identification and screening of endophytic fungi 
Morphological identification of all isolates was 
carried out using lactophenol cotton blue stain. Each 
of the fungal isolates was subjected to submerged 
fermentation (SmF) using soybean meal medium 
consisting of sucrose (50 g/L), soybean meal (20 g/L), 
K2HPO4 (1 g/L), NaNO3 (1 g/L), MgSO4.7H2O  
(0.5 g/L); pH 6.5. The flasks were incubated at 28 °C 
for 7 days in a rotary shaker at 100 rpm25. Two rounds 
of screening were done at this step to ensure the 
consistency of endophytes and check the level of gene 
attenuation at each level of screening. 
 
Lovastatin extraction 
Equal quantity of ethyl acetate was added to the 
fermented material, whose pH was adjusted to 2 using 





1N HCl and kept in a rotary shaker for 2 hours at 100 
rpm for the lovastatin to pass into the organic phase. 
The organic phase is separated and allowed to dry. 
The dried residue is reconstituted in 1 mL ethanol and 
stored at 4 °C till further analysis26. 
 
Qualitative analysis 
The presence of lovastatin in the fermented 
material was confirmed by Thin Layer 
Chromatography (TLC) using Toluene and ethanol as 
a solvent system in the ratio 80:2025. The samples 
were run against standard lovastatin and the Rf values 
were calculated. The antifungal property of lovastatin 
was demonstrated by Saccharomyces cerevisiae 
bioassay on Yeast extract Peptone Dextrose Agar 
(YPDA) plates, ethanol being the control. After 18 
hours of incubation, the zone of inhibition was 
measured27. 
 
Quantification of lovastatin 
Lovastatin was quantified by adding 1 mL of alkaline 
hydroxylamine, 5 mL of ferric perchlorate and 1 mL of 
2N HCl to 0.5 mL of fungal extract and making up the 
volume of the system to 10 mL with ethanol28. After 
incubating the system at room temperature for 25 
minutes, the optical density of the resultant dark purple-
coloured solution was read at 513 nm. 
All the experiments were carried out in triplicates 
and data was expressed as mean±standard error. 
 
Results and Discussion 
A total of 98 fungal isolates were obtained from 
the surface-sterilized plant parts (Table 1). All the 
plant parts studied were found to be inhabited by at 
least one species of endophytes supporting Arnold et 
al.29. The isolates were stained with lactophenol 
cotton blue and observed under the light microscope 
to be Aspergillus sp., Penicillium sp., Fusarium sp., 
Trichoderma sp., Mucor sp., Rhizopus sp., and 
Candida sp. Aspergillus sp. deserves a mention as the 
most commonly isolated fungi from almost all the leaf 
tissues of the medicinal plants under study. 
Raghunath et al.30 reported Aspergillus sp., 
Table 1 — Lovastatin producing endophytic fungi isolated from leaf, stem, root and flower (as applicable) of the plants 
S. No Plant Plant part Organisms No. of Lovastatin producing 
strains 
1 Ocimum tenuiflorum Leaf Aspergillus sp. 5 
Stem Aspergillus sp. 4 
Root Penicillium sp. 3 
2 Emblica officinalis Leaf Aspergillus sp. 5 
Stem Fusarium sp. 1 
Root Aspergillus sp. 3 
3 Moringa oleifera Leaf Trichoderma sp. 2 
Stem Aspergillus sp. 3 
Root Aspergillus sp., Penicillium sp. 6 
4 Bacopa monnieri Leaf Aspergillus sp., Trichoderma sp. 3 
Stem Aspergillus sp. 4 
Root Aspergillus sp. 3 
5 Murraya koenigii Leaf Aspergillus sp. 4 
Stem Aspergillus sp., Mucor sp. 3 
Root Penicillium sp. 3 
6 Azadirachta indica Leaf Aspergillus sp. 3 
Stem Aspergillus sp., Mucor sp. 2 
Root Aspergillus sp., Rhizopus 2 
7 Hibiscus rosa-sinensis Leaf Aspergillus sp., Candida sp. 5 
Stem Aspergillus sp. 3 
Root Aspergillus sp. 4 
Flower Aspergillus sp. 3 
8 Catharanthus roseus Leaf Aspergillus sp., Fusarium sp. 2 
Stem Aspergillus sp. 2 
Root Penicillium sp. 3 
Flower Aspergillus sp. 3 
9 Withania somnifera Leaf Aspergillus sp. 2 
Stem Aspergillus sp. 3 
Root Aspergillus sp,. Penicillium sp. 2 
10 Morinda citrifolia Leaf Aspergillus sp. 3 
Stem Aspergillus sp. 2 
Root Penicillium sp. 2 





Penicillium sp., Alternaria sp., Fusarium sp. and 
Mucor sp. as the most frequently isolated genera from 
endophytic Taxus baccata. 
In the current study, all the isolates except those 
belonging to Mucor sp. and Rhizopus sp. were found 
to be lovastatin producers. The range of yield from 
lovastatin producers in the first round of submerged 
fermentation was recorded between 5 and 71.5 mg/L.  
 
Lovastatin production was first reported from 
Penicillium sp.31 Later several genera such as 
Monascus sp., Aspergillus sp., Paecilomyces sp., 
Trichoderma sp., Phoma sp., Pythium sp., Pleurotus 
sp. and Fusarium sp., have been reported to produce 
lovastatin32-35. Samiee et al.36 documented lovastatin 
production from various species belonging to the 
genus Aspergillus such as Aspergillus terreus, A. 
parasiticus, A.  fischeri, A. flavus and A. umbrosus. In 
studies conducted by Osman et al.37, soil fungi such 
as Aspergillus sp., Penicillium sp., Biospora sp., 
Cylindrocarpon sp. and Trichoderma sp. were 
reported as lovastatin producers. Jaivel and 
Marimuthu38 reported lovastatin production from soil 
isolates such as Aspergillus sp., Monascus sp., 
Penicillium sp., Pleurotus sp. and Trichoderma sp. In 
all the studies cited above, A. terreus was found to be 
the best producer of lovastatin. In contrast to what 
was found in this study, Rhizopus oryzae was reported 
to produce lovastatin with a considerable yield in a 
study conducted by Immanuel et al.39 but from soil 
sources. 
 
Lately, plants are being screened for the isolation of 
potent lovastatin producing endophytic fungi that have 
a yield on par with well exploited and established soil 
fungi. Contradicting the findings of Praveen et al.7 that 
declare endophytes as poor lovastatin producers, there 
are reports on lovastatin production from endophytic A. 
niger PN2 from the leaves of Taxus baccata30 and 
endophytic Phomopsis vexans from the leaves of the 
medicinal plant Solanum xanthocarpum8. Of late, an 
endophytic Aspergillus luchuensis MERV10 isolated 
from marine mangrove was shown to exhibit highest 
lovastatin productivity40. Majority of the studies carried 
out concludes A. terreus as the most promising 
producer of lovastatin and hence it is being used for the 
commercial production of lovastatin at industrial level. 
 
Since endophytes are hindered by a phenomenon 
called gene attenuation on repeated subculturing41, the 
most potent isolates from each level were further 
screened up to three levels to check their potency and 
consistency in terms of lovastatin production. It was 
found that only three isolates from the leaves of 
Hibiscus rosa-sinensis maintained the same yield 
through all rounds of screening. One among the three 
isolates (designated and mentioned further as HL1) 
identified to be Candida sp. is being reported for the 
first time as lovastatin producer in the current study 
with a considerably high yield of 40 mg/L. The other 
two potent isolates (designated and mentioned further 
as HL4 and HL5) were identified to be A. terreus, with 
a yield 21.5 and 18 mg/L respectively. The consistency 
in lovastatin production from these fungi across all 
levels of screening could be attributed to the fact that 
the biosynthesis of the metabolite is inherently encoded 
in the genomes of these endophytic fungi42. The 
methanolic leaf extracts of Hibiscus rosa-sinensis were 
shown to have lipid-lowering ability43. However, the 
study was focused on the phytochemical analysis of the 
leaf extracts and does not explain if the lipid-lowering 
property is attributed to the presence of lovastatin 
producing endophytic fungi. 
TLC results confirm the presence of lovastatin in 
the fungal extract through Rf values which are 0.69 
for the standard lovastatin and 0.70, 0.71, and 0.71 for 
HL1, HL4, and HL5 respectively. The bioassay 
against S. cerevisiae validates antifungal activity of 
the fungal extracts by the formation of a zone of 
inhibition around the wells loaded with the sample. 
The diameter of the zones of inhibition formed by the 
extracts from HL1, HL4 and HL5 was 1.1, 1.2, and 
1.1 cm respectively whereas that formed by standard 
lovastatin was 1.1 cm. 
 
Conclusion 
This study caters to the need for exploiting various 
ecological niches for the isolation of potent lovastatin 
producing fungi. To the best of our knowledge, this is 
the first report on lovastatin production from 
endophytic yeast belonging to Candida sp. with an 
appreciably high yield which is on par with A. terreus 
from other sources. Also, lovastatin production from 
A. terreus with substantial yield from sources other 
than soil is being reported for the first time. Further, 
the production can be scaled up cost-effectively 
through solid-state fermentation using various 
inexpensive and widely available agro and food 
wastes. 
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